Press Releases2020-04-02T07:13:34+00:00

PRESS RELEASES

1903, 2019

Lipum and Abzena sign integrated CMC agreement

March 19th, 2019|

Abzena, the global biologics gene to GMP partner research organization, announced it has signed an agreement to support an integrated CMC program with Lipum, a company developing treatments for chronic inflammatory diseases. Abzena will support [...]

603, 2019

Umeåföretag tar nästa steg mot ett nytt läkemedel

March 6th, 2019|

PRESSMEDDELANDE 2019-03-06 Ladda ned pressrelase: Investerare satsar 25 MSEK på nytt läkemedel (pdf) » Umeåföretaget Lipum utvecklar ett biologiskt läkemedel för behandling av kroniska inflammationer. Tidigare pre-kliniska studier har visat mycket goda resultat och potential [...]

2908, 2018

Lipum receives 2.2 M€ grant from Horizon 2020

August 29th, 2018|

Lipum's unique approach for treatment of chronic inflammatory diseases receives 2.2 M€ support from EU Horizon 2020, the EU framework program for research and development, will grant 2.2 million euros to Lipum’s ongoing development of [...]

INVESTOR RELATIONS